Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
Clinical trial NCT00240019 · COMPLETED
Trial details
- NCT number
- NCT00240019
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.